Xueliang Zuo

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Gas Chromatography

Immune Response

Ejection Fraction

Top Venues

Journal of translational medicine

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Yanna Li, Zhixiong Wang, Peng Gao, Danping Cao, Runyu Dong, Menglin Zhu, Yao Fei, Xueliang Zuo, Juan Cai
CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. Journal of translational medicine 22 (1) (2024)
Yanna Li, Zhixiong Wang, Peng Gao, Danping Cao, Runyu Dong, Menglin Zhu, Yao Fei, Xueliang Zuo, Juan Cai
CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. Journal of translational medicine 22 (1) (2024)
Yanna Li, Zhixiong Wang, Peng Gao, Danping Cao, Runyu Dong, Menglin Zhu, Yao Fei, Xueliang Zuo, Juan Cai
CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. Journal of translational medicine 22 (1) (2024)
Juan Cai, Zhiqiang Chen, Xueliang Zuo
circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer. Disease markers 2019 (2019)
Juan Cai, Zhiqiang Chen, Xueliang Zuo
Response to: Comment on "circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer". Disease markers 2019 (2019)